Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

BOM/543434 stock hub

BOM/543434 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BOM/543434is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

56.9B

Bombay Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BOM/543434

In the news

Latest news · BOM/543434

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E24

P25 n/aP50 n/aP75 n/a

Trailing P/E30.7

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC18.2

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BOM/543434 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

171

Groups with data

Currency

INR

Showing 171 of 171 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	515
Employees Change	67%
Employees Change Percent	14.96
Enterprise value	INR 55.9B
Exchange	Bombay Stock Exchange
Financial currency	INR
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	INR 56.9B
Price	INR 708
Price currency	INR
Rev Per Employee	14,280,699.03x
Sic	2834
Symbol	bom/543434
Website	https://www.supriyalifescience.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.26%
EV Earnings	30.17x
EV/EBIT	23.47x
EV/EBITDA	21.36x
EV/Sales	7.6x
Forward P/E	24.04x
P/B ratio	5.26x
P/E ratio	30.7x
P/S ratio	7.73x
PE Ratio3 Y	26.57x
PE Ratio5 Y	25.03x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	32.38%
EBITDA Margin	35.52%
Gross margin	69.19%
Gross Profit	INR 5.1B
Gross Profit Growth	14.23%
Gross Profit Growth Q	17.25%
Gross Profit Growth3 Y	19.9%
Gross Profit Growth5 Y	45.97%
Net Income	INR 1.9B
Net Income Growth	6.17%
Net Income Growth Q	6.18%
Net Income Growth3 Y	23.72%
Net Income Growth5 Y	84.24%
Pretax Margin	33.55%
Profit Margin	25.19%
Profit Per Employee	INR 3.6M
Roa5y	16.79
Roe5y	28.73
ROIC	18.18
Roic5y	32.06

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	12.39%
Cagr3y	47.17%
EPS Growth	6.36
EPS Growth Q	6.01
EPS Growth3 Y	23.78
EPS Growth5 Y	80.88
Revenue Growth	9.68x
Revenue Growth Q	11.2x
Revenue Growth3 Y	13.21x
Revenue Growth5 Y	27.68x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 1B
Debt	INR 52.3M
Debt EBITDA	INR 0.02
Debt Equity	INR 0
Equity	INR 10.8B
Interest Coverage	375.6
Net Cash	INR 979.8M
Net Cash By Market Cap	INR 1.72
Net Cash Growth	24.34%
Net Debt EBITDA	INR -0.38
Net Debt Equity	INR -0.09
Tangible Book Value	INR 10.8B
Tangible Book Value Per Share	INR 134

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.2%
Dividend Growth	25%
Dividend Growth Years	2%
Dividend per share	INR 1
Dividend Years	4
Dividend Yield	0.14%
Ex Div Date	2025-09-04
Last Dividend	INR 1
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	12.38%
200-day SMA	693.3
3Y total return	218.84%
50-day SMA	632.1
50-day SMA vs 200-day SMA	50under200
All Time High	841.7
All Time High Change	-16.79%
All Time High Date	2025-04-03
All Time Low	170.1
All Time Low Change	311.88%
All Time Low Date	2023-03-27
ATR	25.69
Ch YTD	-6.63
High	712.9
High52	831
High52 Date	2025-11-04
High52ch	-14.83%
Low	698.9
Low52	545.7
Low52 Date	2026-03-24
Low52ch	29.72%
Ma50ch	10.81%
Price vs 200-day SMA	1.02%
RSI	65.13
RSI Monthly	56.25
RSI Weekly	55.99
Sharpe ratio	0.36x
Sortino ratio	0.71
Total Return	0.34%
Tr YTD	-6.63
Tr1m	15.05%
Tr1w	1.19%
Tr3m	4.7%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 2.4B
Operating Income Growth	1.98
Operating Income Growth Q	7
Operating Income Growth3 Y	17.95
Operating Income Growth5 Y	62
Operating margin	32.38

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	25,514,975%
Shares Insiders	68.3%
Shares Institutions	8.83%
Shares Qo Q	0.11%
Shares Yo Y	-0.2%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	28,793.75x
Bv Per Share	134.5
Ch1m	15.05
Ch1w	1.19
Ch1y	12.21
Ch3m	4.7
Ch3y	217.3
Ch6m	-11.2
Change	1.06%
Change From Open	-0.72
Close	700.4
Days Gap	1.78
Depreciation Amortization	231,047,500
Dollar Volume	1,865,053
Earnings Date	2026-05-26
EBIT	INR 2.4B
EBITDA	INR 2.6B
EPS	INR 23.04
F Score	2
Fiscal Year End	March
Founded	1,987
Graham Number	261.50461
Graham Upside	-62.66
Income Tax	INR 614.4M
Is Primary Listing	0
Last Earnings Date	2026-02-09
Last Report Date	2025-12-31
Lynch Fair Value	INR 570
Lynch Upside	-18.56
Ma150	699.1
Ma150ch	0.18%
Ma20	666.2
Ma20ch	5.13%
Next Earnings Date	2026-05-26
Open	712.9
Payment Date	2025-10-24
Position In Range	63.57
Price Date	2026-05-08
Price EBITDA	INR 21.77
Ptbv Ratio	5.26
Relative Volume	0.09x
Revenue	7,354,560,000x
Tax By Revenue	8.35x
Tax Rate	24.9%
Tr6m	-11.2%
Volume	2,635

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BOM/543434 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.1%

$1.00 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

2 consecutive years of growth

Total shareholder yield

+0.3%

Next ex-dividend date: 2025-09-04

Performance

BOM/543434 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BOM/543434?

Insider, institutional, and short-interest positioning.

Institutional ownership

+8.8%

Share of float held by funds and institutions

Insider ownership

+68.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.2%

Negative means the company is buying back shares.

Technical

BOM/543434 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

65.1

Neutral momentum band

Price vs 200-day MA

+1.0%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.36

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BOM/543434

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bom/543434 stock rating?

bom/543434 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bom/543434 analysis?

The full report lives at /stocks/bom/543434/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bom/543434?

The latest report frames bom/543434 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bom/543434 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.